In vitro and in vivo preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by Dispholidus typus

Article

Abstract: Snakebite envenoming affects more than 250,000 people annually in sub-Saharan Africa. Envenoming by

Palabras claves:

Boomslang, drugs, Small molecules, snakebite, SVMP

Autores:

Alsolaiss J., Casewell N.R., Clare R.H., Crittenden E., Edge R.J., Hall S.R., Harrison R.A., Kool J., Marriott A.E., Stefanie K. Menzies, Westhorpe A., Xie C.

Fuentes:

scopus